Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidhartha Hazari

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Virological Methods|January 13, 2004
Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal controlSidhartha Hazari, Subrat Kumar Acharya, Subrat Kumar Panda
The American Journal of Pathology|April 24, 2012
Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298Lili Bao, Sidhartha Hazari, Smriti Mehra, et al.
Microscopy Research and Technique|November 9, 2005
HCV-hepatocellular carcinoma: new findings and hope for effective treatmentSrikanta Dash, Salima Haque, Virendra Joshi, et al.
The American Journal of Pathology|February 2, 2011
Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer modelLili Bao, Aliyya Haque, Kamilah Jackson, et al.
Journal of Gastroenterology and Hepatology|August 12, 2004
Treatment of hepatitis C virus infection in patients of northern IndiaSidhartha Hazari, Subrat Kumar Panda, Siddharth Datta Gupta, et al.
The Journal of Pharmacy and Pharmacology|August 28, 2010
Development of nanosomes using high-pressure homogenization for gene therapyAnup K Kundu, Sidhartha Hazari, Dakshinamurthy Devanga Chinta, et al.
Plos One|October 16, 2010
SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cellsBret Poat, Sidhartha Hazari, Partha K Chandra, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 29, 2011
Development and optimization of nanosomal formulations for siRNA delivery to the liverAnup K Kundu, Partha K Chandra, Sidhartha Hazari, et al.
Virology Journal|September 20, 2007
Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus repliconSidhartha Hazari, Lizeth Taylor, Salima Haque, et al.
International Journal of Pharmaceutics|December 17, 2011
Stability of lyophilized siRNA nanosome formulationsAnup K Kundu, Partha K Chandra, Sidhartha Hazari, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Virological Methods|January 13, 2004
Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal controlSidhartha Hazari, Subrat Kumar Acharya, Subrat Kumar Panda
The American Journal of Pathology|April 24, 2012
Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298Lili Bao, Sidhartha Hazari, Smriti Mehra, et al.
Microscopy Research and Technique|November 9, 2005
HCV-hepatocellular carcinoma: new findings and hope for effective treatmentSrikanta Dash, Salima Haque, Virendra Joshi, et al.
The American Journal of Pathology|February 2, 2011
Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer modelLili Bao, Aliyya Haque, Kamilah Jackson, et al.
Journal of Gastroenterology and Hepatology|August 12, 2004
Treatment of hepatitis C virus infection in patients of northern IndiaSidhartha Hazari, Subrat Kumar Panda, Siddharth Datta Gupta, et al.
The Journal of Pharmacy and Pharmacology|August 28, 2010
Development of nanosomes using high-pressure homogenization for gene therapyAnup K Kundu, Sidhartha Hazari, Dakshinamurthy Devanga Chinta, et al.
Plos One|October 16, 2010
SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cellsBret Poat, Sidhartha Hazari, Partha K Chandra, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 29, 2011
Development and optimization of nanosomal formulations for siRNA delivery to the liverAnup K Kundu, Partha K Chandra, Sidhartha Hazari, et al.
Virology Journal|September 20, 2007
Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus repliconSidhartha Hazari, Lizeth Taylor, Salima Haque, et al.
International Journal of Pharmaceutics|December 17, 2011
Stability of lyophilized siRNA nanosome formulationsAnup K Kundu, Partha K Chandra, Sidhartha Hazari, et al.
Pageof 3